3[1]Howard G,O′Leary D,Zaccaro D,et al.Insulin sensitivity and atherosclerosis.Circulation,1996,93:1809-1817
4[2]Groop L,Ekstrand A,Forsblom C,et al.Insulin resistance,hypertension and microalbuminuria in patients with type II (non-insulin-dependent) diabetes mellitus.Diabetologia,1993,36:642-647
5[3]Steven MHaffner,Ralph D′Agostino Jr,Marian Rewers,et al.Insulin sensitivity in subjects with type 2 diabetes.Diabetes Care,1999,22:562-568
6[4]Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment:insulin resistanceand β-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia,1985,28:412-419
7[5]Bonora E,Kiechl S,Willeit J,et al.Prevalence of insulin resistance in metabolic disorders:the Bruneck Study.Diabetes,1998,47:1643-1649
8[6]Stewart MW,Laker MF,Dyer RG,et al.Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.Arterioscler Thromb,1993,13:1046-1052
9[8]Fukushima M,Taniguchi A,Sakai M,et al.Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients (Letter).Diabetes Care,2000,23:259
10[9]Potter van Loon BJ,Kluft C,Radder JK,et al.The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.Metabolism,1993,42:945-949
1Corrado E,Rizzo M,Coppola G,et al.An update on the role of markers of inflammation in atherosclerosis[J].Atheroscler Thromb,2010,17:1-11.
2Wiwanitkit V.hs-CRP as a predictive factor for cardiac outcome[J].Ann Card Anaesth,2010,13:74.
3Sch(o)ndorf T,Lübben G,Karagiannis E,et al.Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists:results from the DIASPORA study[J].Diab Vasc Dis Res,2010,7:145-150.
4Asselbergs F W,Williams S M,Hebert P R,et al.Gender-specific correlations of PAI-1 and t-PA levels with cardiovascular disease-related traits[J].J Thromb Haemost,2007,5:313-320.
5Pfutzner A,Standl E,Strotmann H J,et al.Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus[J].Clin Chem Lab Med,2006,44(5):556-560.
6HAHR A J, MOLITCH M E. Diabetes, cardiovascular risk and nephropathy[J]. Cardiol Clin, 2010,28 : 467 -475.
7Ameriean Diabetes Association. Standards of medical care in diabetes-2010[J]. Diabetes Care, 2010,33 :S11 -S61.
8MOJAHEDI M J, BONAKDARAN S, HAMI M, et al. Elevated serum C-reactive protein level and mi croalbuminuria in patients with type 2 diabetes mellitus[J]. Iran J Kidney Dis, 2009,3 : 12- 16.
9DATTA P,DASGUPTA A. An improved microalbumin method (microALB 2) with extended analytical measurement range evaluated on the ADVIA chemistry systems[J]. J ('lin Lab Anal,2009,23:314-318.
